In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in patients with advanced ovarian cancer.

The changed landscape has also been a result of redefining the definition of survivor in cancer care. “As cancer care evolves, so has survivorship, and really the way that we define it,” Sweeney said, ...

Non-small cell lung cancer (NSCLC) is the most common malignancy worldwide, with up to 50% of patients developing brain metastases (BMs) in their disease course and 70% of BMs developing multiple ...

The study results indicated that family support significantly negatively impacts death anxiety in breast cancer patients; similarly, meaning in life also significantly negatively impacts death anxiety ...